Faron to Present at the Virtual H.C. Wainwright Global Investor Conference
Faron Pharmaceuticals Ltd (“Faron”) Faron to Present at the Virtual H.C. Wainwright Global Investor Conference TURKU, FINLAND / BOSTON, MA, September 7, 2021 – Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, today announced that Dr. Juho Jalkanen, Chief Development Officer of Faron, will present at the virtual H.C. Wainwright Global Investor Conference. Dr. Jalkanen’s presentation will be